FAM171B stabilizes vimentin and enhances CCL2-mediated TAM infiltration to promote bladder cancer progression

FAM171B stabilizes vimentin and enhances CCL2-mediated TAM infiltration to promote bladder cancer progression

Abstract Background Invasion and metastasis are the main causes of unfavourable prognosis in patients diagnosed with bladder cancer. The efficacy of immunotherapy in bladder cancer remains suboptimal due to the presence of an immunosuppressive microenvironment. The novel protein family with sequence...

Full description

Bibliographic Details
Main Authors:	Wei-Min Hu, Ming Li, Jin-Zhuo Ning, Yu-Qi Tang, Tian-Bao Song, Lin-Zhi Li, Fan Zou, Fan Cheng, Wei-Min Yu
Format:	Article
Language:	English
Published:	BMC 2023-11-01
Series:	Journal of Experimental & Clinical Cancer Research
Subjects:	Bladder cancer CCL2 Macrophage Vimentin
Online Access:	https://doi.org/10.1186/s13046-023-02860-5

Similar Items

The Immunohistochemical Staining of Vimentin and E-Cadherin in Bladder Cancer Patients Infected with Hepatitis C Virus
by: May K. Ismael, et al.
Published: (2023-06-01)

Pexidartinib synergize PD-1 antibody through inhibiting treg infiltration by reducing TAM-derived CCL22 in lung adenocarcinoma
by: Wei Zhang, et al.
Published: (2023-03-01)

Plasma Membrane Localization of CD36 Requires Vimentin Phosphorylation; A Mechanism by Which Macrophage Vimentin Promotes Atherosclerosis
by: Seo Yeon Kim, et al.
Published: (2022-05-01)

Vaccination against Extracellular Vimentin for Treatment of Urothelial Cancer of the Bladder in Client-Owned Dogs
by: Diederik J. M. Engbersen, et al.
Published: (2023-08-01)

Practicability of clinical application of bladder cancer molecular classification and additional value of epithelial-to-mesenchymal transition: prognostic value of vimentin expression
by: João Lobo, et al.
Published: (2020-08-01)

Cellular vimentin regulates the infectivity of Newcastle disease virus through targeting of the HN protein
by: Xiaolong Lu, et al.
Published: (2023-10-01)

CCL22-Polarized TAMs to M2a Macrophages in Cervical Cancer In Vitro Model
by: Qun Wang, et al.
Published: (2022-06-01)

HUCMSC‐derived Exosomes Suppress the Titanium Particles‐induced Osteolysis in Mice through Inhibiting CCL2 and CCL3
by: Shixun Li, et al.
Published: (2023-03-01)

Vimentin as a Multifaceted Player and Potential Therapeutic Target in Viral Infections
by: Irene Ramos, et al.
Published: (2020-06-01)

Detection of Anti-Vimentin Antibodies in Patients with Sarcoidosis
by: Anna Starshinova, et al.
Published: (2022-08-01)

Extracellular vimentin is expressed at the rear of activated macrophage-like cells: Potential role in enhancement of migration and phagocytosis
by: Divyendu Goud Thalla, et al.
Published: (2022-07-01)

Macrophages and vimentin in tissues adjacent to megaprostheses and mesh in reconstructive surgeries
by: Kunihiro Asanuma, et al.
Published: (2022-12-01)

Lactate-Induced CCL8 in Tumor-Associated Macrophages Accelerates the Progression of Colorectal Cancer through the CCL8/CCR5/mTORC1 Axis
by: Hui Zhou, et al.
Published: (2023-12-01)

Biomarker Potential of Vimentin in Oral Cancers
by: Saie Mogre, et al.
Published: (2022-01-01)

Progress of vimentin in hepatocellular carcinoma
by: DONG Bao-long, HAN Cai-wen, SHI Ming, ZHENG Wen-xue, YANG Xiao-jun
Published: (2020-02-01)

Dexamethasone impact on vimentin in human lens epithelial cells
by: Su Sheng, et al.
Published: (2016-01-01)

FOXD1 Promotes Cell Growth and Metastasis by Activation of Vimentin in NSCLC
by: Dan Li, et al.
Published: (2018-12-01)

CircGLIS3 promotes gastric cancer progression by regulating the miR-1343-3p/PGK1 pathway and inhibiting vimentin phosphorylation
by: Yongxin Zhang, et al.
Published: (2024-03-01)

Vimentin Phosphorylation Is Required for Normal Cell Division of Immature Astrocytes
by: Yolanda de Pablo, et al.
Published: (2019-09-01)

Relationship of Anti-vimentin antibodies to anti-endothelial antibodies
by: Malickova Karin, et al.
Published: (2006-09-01)

Identification of a novel autoantibody against self-vimentin specific in secondary Sjögren’s syndrome
by: Yu-Hui Li, et al.
Published: (2018-02-01)

The GBM Tumor Microenvironment as a Modulator of Therapy Response: ADAM8 Causes Tumor Infiltration of Tams through HB-EGF/EGFR-Mediated CCL2 Expression and Overcomes TMZ Chemosensitization in Glioblastoma
by: Xiaojin Liu, et al.
Published: (2022-10-01)

The alterations of cytokeratin and vimentin protein expressions in primary esophageal spindle cell carcinoma
by: Xin Min Li, et al.
Published: (2018-04-01)

CCL2 Expression in Tumor Cells and Tumor-Infiltrating Immune Cells Shows Divergent Prognostic Potential for Bladder Cancer Patients Depending on Lymph Node Stage
by: Markus Eckstein, et al.
Published: (2020-05-01)

VDR promotes pancreatic cancer progression in vivo by activating CCL20-mediated M2 polarization of tumor associated macrophage
by: Hengzhen Li, et al.
Published: (2024-04-01)

Vimentin expression is a predictor of renal dysfunction after kidney transplantation
by: Ana Cristina Carvalho de Matos, et al.
Published: (2007-06-01)

Chemokine CCL9 Is Upregulated Early in Chronic Kidney Disease and Counteracts Kidney Inflammation and Fibrosis
by: Christian Hemmers, et al.
Published: (2022-02-01)

Vimentin immunoexpression and its prognostic activity in colon cancer among Caucasian patients
by: Marlena Brzozowa-Zasada, et al.
Published: (2022-06-01)

The Spleen Promotes the Secretion of CCL2 and Supports an M1 Dominant Phenotype in Hepatic Macrophages During Liver Fibrosis
by: Liang Li, et al.
Published: (2018-11-01)

Characterization of Vimentin-Immunoreactive Astrocytes in the Human Brain
by: Liam Anuj O’Leary, et al.
Published: (2020-07-01)

Relationship between vimentin and glucocorticoid-induced cataract
by: Jia-Jia Ge, et al.
Published: (2014-11-01)

CCL5 promotes breast cancer recurrence through macrophage recruitment in residual tumors
by: Andrea Walens, et al.
Published: (2019-04-01)

Single-cell RNA sequencing reveals recruitment of the M2-like CCL8high macrophages in Lewis lung carcinoma-bearing mice following hypofractionated radiotherapy
by: Haonan Yang, et al.
Published: (2024-03-01)

Vimentin Tail Segments Are Differentially Exposed at Distinct Cellular Locations and in Response to Stress
by: Irene Lois-Bermejo, et al.
Published: (2022-06-01)

Vimentin and Anti Vimentin Antibodies in Chagas' Disease
by: Marilda Savoia Nascimento, et al.
Published: (2018-03-01)

Activated Hepatic Stellate Cells Induce Infiltration and Formation of CD163+ Macrophages via CCL2/CCR2 Pathway
by: Sujuan Xi, et al.
Published: (2021-02-01)

Anti-Vimentin Nanobody Decreases Glioblastoma Cell Invasion In Vitro and In Vivo
by: Alja Zottel, et al.
Published: (2023-01-01)

Proteomic Analysis Implicates Vimentin in Glioblastoma Cell Migration
by: Michal O. Nowicki, et al.
Published: (2019-04-01)

Histamine Increases Th2 Cytokine-Induced CCL18 Expression in Human M2 Macrophages
by: Susanne Mommert, et al.
Published: (2021-10-01)

CHEMOKINES CCL17 AND CCL22 IN SARCOIDOSIS
by: N. M. Lazareva, et al.
Published: (2021-10-01)